E-LIB Suche - Ergebnisse für: Rodriguez-Otero, P. (Paula)

1

International Myeloma Working Group immunotherapy committee..:

Rodriguez-Otero, Paula ; Usmani, Saad ; Cohen, Adam D...
The Lancet Oncology. 25 (2024) 5 - p. e205-e216 , 2024

Link: https://doi.org/10.1016/..

2

Preclinical models for prediction of immunotherapy outcomes..:

Larrayoz, Marta ; Garcia-Barchino, Maria J. ; Celay, Jon...
Nature Medicine. 29 (2023) 3 - p. 632-645 , 2023

Link: https://doi.org/10.1038/..

3

Phase 1b Study of Isatuximab in combination with bortezomib..:

Ocio, E.M. (Enrique M.) ; Bringhen, S. (Sara) ; Martínez-López, J. (Joaquín)...
https://hdl.handle.net/10171/65975. , 2023

Link: https://hdl.handle.net/1..

4

Cobimetinib Alone and Plus Venetoclax With/Without Atezoliz..:

Schjesvold, F.H. (Fredrik H.) ; Lourenco-Paiva, B.D. (Bruno David) ; Ribrag, V. (Vincent)...
https://pubmed.ncbi.nlm.nih.gov/36450626/. , 2023

Link: https://hdl.handle.net/1..

5

Daratumumab, carfilzomib, and dexamethasone in relapsed or ..:

Moreau, P. (Philippe) ; Chari, A. (Ajai) ; Oriol, A. (Albert)...
https://pubmed.ncbi.nlm.nih.gov/36882409/. , 2023

Link: https://hdl.handle.net/1..

6

Preclinical models for prediction of immunotherapy outcomes..:

Larrayoz, M. (Marta) ; García-Barchino, M.J. (María José) ; Celay, J. (Jon)...
info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI19%2F00818/ES/INMUNOTERAPIA PERSONALIZADA EN MIELOMA MULTIPLE A TRAVES DEL USO DE MODELOS EXPERIMENTALES EN RATON. , 2023

Link: https://hdl.handle.net/1..

7

Analysis of patient-reported experiences up to 2 years afte..:

Delforge, M. (M.) ; Rodriguez-Otero, P. (Paula) ; Shah, N. (Nina)...
https://pubmed.ncbi.nlm.nih.gov/37087950/. , 2023

Link: https://hdl.handle.net/1..

8

11C-methionine PET/CT in assessment of multiple myeloma pat..:

Morales-Lozano, M. I. (Mª Isabel) ; Rodriguez-Otero, P. (Paula) ; Sancho-Rodriguez, L. (Lidia)...
info:eu-repo/grantAgreement/MINECO/Proyectos de investigación en salud (Modalidad Proyectos de investigación en salud) (AE Salud 2016)/PI16%2F00225/ES/Evaluación de 18F-FDG, 11C-MET y 11C-COL para la detección de infiltración tumoral en Mieloma Múltiple (MM): Estudio traslacional en modelos preclínico y clínico en pacientes (MIELOMAPET). , 2022

Link: https://hdl.handle.net/1..

9

Prognostic value of serum paraprotein response kinetics in ..:

Tamariz-Amador, L.E. (Luis Esteban) ; Rodriguez-Otero, P. (Paula) ; Jiménez-Ubieto, A. (Ana)...
https://pubmed.ncbi.nlm.nih.gov/35688793/. , 2022

Link: https://hdl.handle.net/1..

10

Prognostic value of serum paraprotein response kinetics in ..:

Tamariz-Amador, L.E. (Luis Esteban) ; Rodriguez-Otero, P. (Paula) ; Jiménez-Ubieto, A. (Ana)...
https://hdl.handle.net/10171/66125. , 2022

Link: https://hdl.handle.net/1..

11

Matching adjusted indirect comparisons of efficacy outcomes..:

Rodriguez-Otero, Paula ; Ayers, Dieter ; Cope, Shannon...
Leukemia & Lymphoma. 62 (2021) 10 - p. 2482-2491 , 2021

Link: https://doi.org/10.1080/..

12

Roadmap to cure multiple myeloma:

Rodriguez-Otero, P. (Paula) ; Paiva, B. (Bruno) ; San-Miguel, J.F. (Jesús F.)
https://hdl.handle.net/10171/63392. , 2021

Link: https://hdl.handle.net/1..

13

Ultra-low dose whole-body CT for attenuation correction in ..:

Prieto-Azcárate, E. (Elena) ; Garcia-Velloso, M. J. (María José) ; Aquerreta, D. (Dámaso)...
https://hdl.handle.net/10171/63583. , 2021

Link: https://hdl.handle.net/1..

14

Reference values to assess hemodilution and warn of potenti..:

Puig, N. (Noemí) ; Montero, J. (Juan) ; Burgos, L. (Leire)...
info:eu-repo/grantAgreement/EC/H2020/680200/EU. , 2021

Link: https://hdl.handle.net/1..

15

Results of an early access treatment protocol of daratumuma..:

Alegre, A. (A.) ; Rubia, J. (Javier) de la ; Sureda-Balari, A. (Anna)...
https://hdl.handle.net/10171/67676. , 2020

Link: https://hdl.handle.net/1..